| Tag | Content |
|---|
EnhancerAtlas ID | HS019-10873 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr22:30667830-30668800 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr22:30668727-30668745 | GGGAGAGAGGGAGGAAGG | + | 6.27 | | EWSR1-FLI1 | MA0149.1 | chr22:30668731-30668749 | GAGAGGGAGGAAGGAAGG | + | 7.25 | | EWSR1-FLI1 | MA0149.1 | chr22:30668735-30668753 | GGGAGGAAGGAAGGAAAC | + | 7.63 | | TBX21 | MA0690.1 | chr22:30668434-30668444 | TTCACACCTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_00207 | chr22:30666824-30668001 | Adipose_Nuclei |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTTGAGACCA GCCTGGCCAA CGTAGTGAAA CTCCAACTCT ACTAAAAGTA CAAAAAATTA 60
CGCAGGCATG GTAGCACTCG CCGGTAGTCC CAGCTACTCG GGAGACTGAG GCAGGAGAAT 120
TGCTTGAACC TGGGAGGCGG AGGTTGCAGT GAGCCAAGAT TGTGCCACTA CCCTCCAGTC 180
TGGGTGACAG AGTGAGACAC TGTCTCAAAA AAAAAAAAAA TAAATAGAGA TATCATATAA 240
CCAACAATTC CACTCCTAGA TATACACCCA AGAGAATTGA AAACATAGGC CAGGTGCAGT 300
GGTCAGACCT GTAATCCCAG CACTTTGGGA GGCCAAGATG GGAGGATCAC TTGAGCCCAG 360
GAGTTCAAGA CCAGCCTGGC CAAAAAAGTG AGACCCCATC TCTACAAAAC ATTTAAAAAT 420
TAGCTGAGCA TGGTGGCTTG CACCTGTGTG GTCCCAGCTA CTCAGGAAGC TGAGACCGAA 480
AGATCACTTG AGCCTGCGAG GTCAAGGCTG CAGTGAGCCA TATTCATACC ACTGCACTCC 540
AGCCTGAGTG ACAGAGTGAG ACTCTGTCTC TGGACAAAAA AAAAAAAGAG GCTGAGCACG 600
GTGGTTCACA CCTTTAATCC CAGCACTTTG GGAAGCCAAG GCAGGTGGAT CACCTGAGGT 660
CGGGAGTTCA AGACCAGCCT GGCCAACATG GTGAAACTCC ATCTCTACTA AAGATACAAA 720
AATTAGCTGG GCATGGTGGC GCACGCCTGT AATCCTAGCT ACTCAGGAGA CTGAGGCAGG 780
AGAATCACTT GAATCTGGGA GGTGGAAGCT GCAGTGAGCT GAGATCGCGC CTTTGCTCTC 840
TAGCCTGGCA ACAAGAGCGA AACGCCAAAA AAAATAAGAA AGAGAGAAAG AGAGAGTGGG 900
AGAGAGGGAG GAAGGAAGGA AACGTACATC CACACAAAAA CTTGCAAATG TTCATAGGAG 960
CAATTATTCG 970
|
